Navigation Links
Annual Survey Demonstrates Increased Demand for Anesthesia Information Management Systems
Date:10/13/2011

ATLANTA, Oct. 13, 2011 /PRNewswire/ -- Anesthesiologists are quickly turning to Anesthesia Information Management Systems (AIMS) to help deliver cost-effective, high quality care.  An annual survey of anesthesia providers shows an increased demand for AIMS with 57% of survey respondents indicating that IT solutions are a high priority. 63% reported meaningful use requirements as a key driver in IT decisions.  The survey of 212 anesthesia providers was sponsored by Surgical Information Systems.

(Logo: http://photos.prnewswire.com/prnh/20080722/SISLOGO)

"This survey mirrors the AIMS demand we are seeing in the market," said Ed Daihl, CEO, Surgical Information Systems.

"Electronic anesthesia documentation enables fast, complete and legible anesthesia records, facilitating billing and providing a rich data set of information and analytics to be used for quality improvement and cost control efforts.  These are significant benefits; especially given the direction healthcare is headed."

In the survey, 43% report that they are either using or planning to implement an AIMS with an additional 28% evaluating systems in the next year. Key drivers cited for investment in AIMS include OR efficiencies to be gained from an electronic chart, analytics capabilities, improved communications, and support for mobile devices to cover all anesthesia sites within the hospital.  

40% of respondents state Quality of Patient Care as their top work concern. An AIMS supports quality by providing workflow driven documentation that maximizes caregiver time with patients and provides information for analysis afterwards.  

Decreasing Reimbursements was the second most stated work concern. As payment models shift from volume to outcomes, the ability to provide documented, high-quality care is a key focus. Survey respondents reported key cost reduction efforts that include:

  • Enhancing OR efficiency. Utilizing electronic records for better charting, billing and OR management including using analytics to monitor metrics like OR times, anesthesia turnovers and drug usage.
  • Improving purchasing power. Implementing electronic documentation, charge capture and analytics provides rich data to better negotiate with suppliers for drugs, supplies, and equipment.
  • Reducing waste. Limiting unnecessary use of supplies, drugs, and blood.

An AIMS that includes analytics provides anesthesia providers with clinical intelligence, giving them access to metrics such as anesthesia times, surgical times, and outcomes by caregiver. With the ability to analyze outcome quality, anesthesia providers can monitor and improve efficiencies, strengthen their purchasing power, and reduce unnecessary supplies.

"The interest in AIMS is growing due to the value they deliver in meeting top hospital objectives for care quality and financial performance," said Daihl.  "An AIMS with anesthesia focused analytics unlocks decision making data to help anesthesia providers and hospitals improve both quality of care and financial return."  

About SIS

Surgical Information Systems ("SIS") provides software solutions that are uniquely designed to add value at every point of the perioperative process. Developed specifically for the complex surgical environment, all SIS solutions – including anesthesia – are architected on a single database and integrate easily with other hospital systems. SIS offers the only surgical scheduling system and the only anesthesia information management system endorsed by the American Hospital Association (AHA), and a rules-based charging system that has been granted Peer Reviewed status by the Healthcare Financial Management Association (HFMA). SIS is also the first AIMS provider to be designated as an AQI Preferred Vendor by the Anesthesia Quality Institute (AQI).

For more information visit our website, www.SISFirst.com.


'/>"/>
SOURCE Surgical Information Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
2. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
3. Oculus Innovative Sciences to Present at 4th Annual BIO InvestorForum Conference
4. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
5. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
6. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
7. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
8. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
9. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
10. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
11. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)... 2017  Researchers from DRUGSCAN ® and INC ... a live, complimentary webinar titled, "Untangling methods to tamper ... real world" on Wednesday June 28, 2017 from 12:00 ... webinar will feature interviews with recreational and dependent prescription ... techniques abusers use to prepare opioid tablets for routes ...
(Date:6/14/2017)... 14, 2017  ivWatch LLC, a medical device company ... (IV) therapy, is pleased to announce it was the ... Hospital Supplies and Equipment at the 2017 Medical Design ... medtech industry. The award was presented by Medical Device ... Center in New York during ...
(Date:6/13/2017)... , June 13, 2017 Zimmer Biomet Holdings, Inc. ... today announced that the U.S. Food and Drug Administration (FDA) ... 3, 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning Letter ... manufacturing facility is a measure of the progress we have ...
Breaking Medicine Technology:
(Date:6/20/2017)... ... June 20, 2017 , ... After months of negotiations, FaceCradle USA is proud to ... on Wednesday, June 21. , “Introducing our product on QVC is something we all worked ... our travel pillow to more than 90 million homes in the United States,” said FaceCradle ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... the introduction of school choice can promote economic development in economically distressed urban ... has, according to the report, contributed to the economic development of the city ...
(Date:6/20/2017)... ... 2017 , ... Dr. Manju R. Kejriwal currently accepts new ... or not they have a referral. Dr. Kejriwal offers state-of-the-art treatment through the ... bacteria and damaged tissue without affecting the surrounding tissue. This technology virtually eliminates ...
(Date:6/20/2017)... ... 20, 2017 , ... Many RNA binding proteins (RBPs) regulate ... team developed expressRNA, a web platform encompassing computational tools for integration of the ... the ‘RNA maps’, which demonstrate that RBPs bind to specific positions on pre-mRNAs ...
(Date:6/20/2017)... ... June 20, 2017 , ... John D'Eri, CEO of Rising Tide ... Adult Autism Award during the Autism Society of America 's 49th annual ... Daniel Jordan Fiddle Foundation (DJFF) was founded in 2002 as the nation's first ...
Breaking Medicine News(10 mins):